OBJECTIVES: Vaginal pH is related to hormonal status, and adolescents experience disturbed hormonal patterns following menarche. We assessed hormonal factors and risk of abnormal vaginal pH and bacterial vaginosis (BV) among adolescents attending genitourinary medicine (GUM) clinics. METHODS: In a cross sectional study adolescents within 5 years of menarche, < or =17 years, or with oligo-amenorrhoea were recruited. Vaginal pH and BV were assessed and among those not using hormonal contraceptives, estrone-3-glucuronide (E3G) and pregnanediol-3alpha-glucuronide (P3G) concentrations were measured. RESULTS: Among 102 adolescents, 59.8% (61) had a high vaginal pH (>4.5), which was higher than the prevalence of BV, detected in 33% (34). No association was found between presence of sexually transmitted infections (STI) and vaginal pH. In logistic regression, after controlling for BV and condom use, vaginal pH was positively associated with cervical ectopy (OR = 2.5; 95% CI 1.0 to 6.6, p = 0.05) and STI treatment history (OR = 2.5; 95% CI 0.9 to 6.5, p = 0.07), and negatively associated with use of Depo-Provera (OR = 0.1; 95% CI 0.03 to 0.6, p = 0.003) and recent onset (<12 months) of sexual activity (OR = 0.2; 95% CI 0.1 to 0.7, p = 0.004). Among 23 adolescents not using hormonal contraceptives, a high pH occurred more often in abnormal compared to normal menstrual cycles (OR = 10.8; 95% CI 1.4 to 85.4; p = 0.026). E3G concentrations were inversely correlated with vaginal pH in the follicular phase (Spearman: r = 0.51; p = 0.024). CONCLUSIONS: Ectopy and abnormal menstrual cycles are common features of adolescence. Their presence is associated with increased risk of abnormal pH, and may also predispose to BV.
OBJECTIVES: Vaginal pH is related to hormonal status, and adolescents experience disturbed hormonal patterns following menarche. We assessed hormonal factors and risk of abnormal vaginal pH and bacterial vaginosis (BV) among adolescents attending genitourinary medicine (GUM) clinics. METHODS: In a cross sectional study adolescents within 5 years of menarche, < or =17 years, or with oligo-amenorrhoea were recruited. Vaginal pH and BV were assessed and among those not using hormonal contraceptives, estrone-3-glucuronide (E3G) and pregnanediol-3alpha-glucuronide (P3G) concentrations were measured. RESULTS: Among 102 adolescents, 59.8% (61) had a high vaginal pH (>4.5), which was higher than the prevalence of BV, detected in 33% (34). No association was found between presence of sexually transmitted infections (STI) and vaginal pH. In logistic regression, after controlling for BV and condom use, vaginal pH was positively associated with cervical ectopy (OR = 2.5; 95% CI 1.0 to 6.6, p = 0.05) and STI treatment history (OR = 2.5; 95% CI 0.9 to 6.5, p = 0.07), and negatively associated with use of Depo-Provera (OR = 0.1; 95% CI 0.03 to 0.6, p = 0.003) and recent onset (<12 months) of sexual activity (OR = 0.2; 95% CI 0.1 to 0.7, p = 0.004). Among 23 adolescents not using hormonal contraceptives, a high pH occurred more often in abnormal compared to normal menstrual cycles (OR = 10.8; 95% CI 1.4 to 85.4; p = 0.026). E3G concentrations were inversely correlated with vaginal pH in the follicular phase (Spearman: r = 0.51; p = 0.024). CONCLUSIONS: Ectopy and abnormal menstrual cycles are common features of adolescence. Their presence is associated with increased risk of abnormal pH, and may also predispose to BV.
Authors: D A Eschenbach; S S Thwin; D L Patton; T M Hooton; A E Stapleton; K Agnew; C Winter; A Meier; W E Stamm Journal: Clin Infect Dis Date: 2000-06-13 Impact factor: 9.079
Authors: L Brabin; E Fairbrother; D Mandal; S A Roberts; S P Higgins; S Chandiok; P Wood; G Barnard; H C Kitchener Journal: Sex Transm Infect Date: 2005-04 Impact factor: 3.519
Authors: Rebecca M Brotman; Emily J Erbelding; Roxanne M Jamshidi; Mark A Klebanoff; Jonathan M Zenilman; Khalil G Ghanem Journal: J Pediatr Adolesc Gynecol Date: 2007-08 Impact factor: 1.814
Authors: Marie E Thoma; Ronald H Gray; Noah Kiwanuka; Simon Aluma; Mei-Cheng Wang; Nelson Sewankambo; Maria J Wawer Journal: J Pediatr Adolesc Gynecol Date: 2010-08-14 Impact factor: 1.814
Authors: Roxana J Hickey; Xia Zhou; Matthew L Settles; Julie Erb; Kristin Malone; Melanie A Hansmann; Marcia L Shew; Barbara Van Der Pol; J Dennis Fortenberry; Larry J Forney Journal: MBio Date: 2015-03-24 Impact factor: 7.867
Authors: Brooke A Clemmons; Sydney T Reese; Felipe G Dantas; Gessica A Franco; Timothy P L Smith; Olusoji I Adeyosoye; Ky G Pohler; Phillip R Myer Journal: Front Microbiol Date: 2017-06-08 Impact factor: 5.640
Authors: Elise S Pelzer; John A Allan; Christina Theodoropoulos; Tara Ross; Kenneth W Beagley; Christine L Knox Journal: PLoS One Date: 2012-12-04 Impact factor: 3.240
Authors: Andrew Vallely; Lisa Fitzgerald; Voletta Fiya; Herick Aeno; Angela Kelly; Joyce Sauk; Martha Kupul; James Neo; John Millan; Peter Siba; John M Kaldor Journal: BMC Res Notes Date: 2012-11-01